Publications by authors named "Peter L Roberson"

Claim this Profile
P
Prediction of Tumor Control in Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics.
Yuni K Dewaraja, Theresa Devasia, Ravi K Kaza, Justin K Mikell, Dawn Owen, Peter L Roberson

J Nucl Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization.
Justin K Mikell, Ravi K Kaza, Peter L Roberson, Kelly C Younge, Ravi N Srinivasa

EJNMMI Phys· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.
Peter L Roberson, Lauren B Smith, Meredith A Morgan, Matthew J Schipper, Scott J Wilderman

Cancer Biother Radiopharm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a 2D detector array for meaningful and efficient linear accelerator beam property validations.
Timothy A Ritter, Ian Gallagher, Peter L Roberson

J Appl Clin Med Phys· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.
Yuni K Dewaraja, Matthew J Schipper, Jincheng Shen, Lauren B Smith, Jure Murgic, Peter L Roberson

J Nucl Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Audit tool for external beam radiation therapy departments.
Timothy Ritter, James M Balter, Choonik Lee, Don Roberts, Peter L Roberson

Pract Radiat Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parameters.
Peter L Roberson, Scott J Wilderman, Anca M Avram, Mark S Kaminski, Matthew J Schipper

Cancer Biother Radiopharm· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma.
Peter L Roberson, Hanan Amro, Scott J Wilderman, Anca M Avram, Mark S Kaminski

Eur J Nucl Med Mol Imaging· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of variation in calibration curves for Kodak XV radiographic film using model-based parameters.
Shu-Hui Hsu, Ravi Kulasekere, Peter L Roberson

J Appl Clin Med Phys· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling.
Yuni K Dewaraja, Matthew J Schipper, Peter L Roberson, Scott J Wilderman, Hanan Amro

J Nucl Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose discrepancies in the buildup region and their impact on dose calculations for IMRT fields.
Shu-Hui Hsu, Jean M Moran, Yu Chen, Ravi Kulasekere, Peter L Roberson

Med Phys· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.
Hanan Amro, Scott J Wilderman, Yuni K Dewaraja, Peter L Roberson

J Nucl Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic film dosimetry for IMRT fields in the nearsurface buildup region.
Peter L Roberson, Jean M Moran, Ravi Kulasekere

J Appl Clin Med Phys· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of skin dose for breast chest wall radiotherapy as a function of bolus material.
Shu-Hui Hsu, Peter L Roberson, Yu Chen, Robin B Marsh, Lori J Pierce

Phys Med Biol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of rapid radiographic film calibration for intensity-modulated radiation therapy verification.
Ravi Kulasekere, Jean M Moran, Benedick A Fraass, Peter L Roberson

J Appl Clin Med Phys· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface buildup dose dependence on photon field delivery technique for IMRT.
Shigeru Yokoyama, Peter L Roberson, Dale W Litzenberg, Jean M Moran, Benedick A Fraass

J Appl Clin Med Phys· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted radiation for melanoma: alpha therapy prepares for a beta test.
Joseph N Contessa, Peter L Roberson

Cancer Biol Ther· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional anatomy of the prostate: implications for treatment planning.
Patrick W McLaughlin, Sara Troyer, Sally Berri, Vrinda Narayana, Amichay Meirowitz, Peter L Roberson

Int J Radiat Oncol Biol Phys· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Buck E Rogers, Peter L Roberson, Sui Shen, M B Khazaeli, Mark Carpenter

Cancer Biother Radiopharm· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of mutual information in registration of CT and MRI datasets post permanent implant.
Patrick W McLaughlin, Vrinda Narayana, Marc Kessler, Daniel McShan, Sara Troyer, Peter L Roberson

Brachytherapy· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate.
Peter L Roberson, P William McLaughlin, Vrinda Narayana, Sara Troyer, George V Hixson

Med Phys· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.
Patrick W McLaughlin, Vrinda Narayana, Amichay Meirovitz, Sara Troyer, Peter L Roberson

Int J Radiat Oncol Biol Phys· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of high- and low-source strength (125)I prostate seed implants.
Vrinda Narayana, Sara Troyer, Vicki Evans, Raymond J Winfield, Peter L Roberson

Int J Radiat Oncol Biol Phys· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.
Peter L Roberson, Shigeru Yokoyama, Buck E Rogers, Donald J Buchsbaum

Cancer Biother Radiopharm· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis